Loading data for STTK — first visit, this takes a few seconds.
Shattuck Labs Inc. (STTK)
NasdaqGS: STTK
· Real-Time Price · USD
7.90
+0.37 (4.91%)
At close: Aug 27, 2026, 3:59 PM
The price, the headline numbers and the latest news, in one place.
Shattuck Labs Inc. (STTK) Stock Price, Analysis & Data
4.91% (1D)
| Bid | 5.3 |
| Market Cap | 747.71M |
| Revenue (ttm) | 1M |
| Net Income (ttm) | -52.57M |
| 1.11 | |
| -0.44 | |
| n/a | |
| -14.2 | |
| P/B (ttm) | 5.88 |
| P/S (ttm) | 747.71 |
| Earnings Date | Nov 12, 2026 |
| Ask | 9.31 |
| Volume | 2,054,565 |
| Avg. Volume (20D) | 1,340,684 |
| Open | 7.66 |
| Previous Close | 7.53 |
| Day's Range | 7.50 - 8.02 |
| 52-Week Range | 0.92 - 8.33 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About STTK
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic goo...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 9, 2020
Employees 40
Stock Exchange NasdaqGS
Ticker Symbol STTK
Website https://www.shattucklabs.com
Financial Performance
In 2025, Shattuck Labs's revenue was 1M, a decrease of -82.52% compared to the previous year's 5.72M. Earnings were -48.81M, a decrease of -35.28%.
Financial StatementsEarnings Surprise
Shattuck Labs has released their quarterly earnings on Aug 11, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.12 misses estimates by 0.00, with 50.00% YoY growth.
Shattuck Labs Inc. is scheduled to release its earnings on Nov 12, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2